{
  "retracted": false,
  "timestamp": 1391904000000,
  "updates": [
    {
      "timestamp": 1585549966879,
      "identifier": {
        "doi": "10.1007/s10637-014-0069-6"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10637-013-0062-5"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Phase I study of PF-04691502, a small-molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer"
}
